CV2- COST-EFFECTIVENESS OF TREATING HIGH-RISK INDIVIDUALS, AGED 45-65, WITH STATINS IN GERMANY FOR PRIMARY AND SECONDARY PREVENTION OF CORONARY HEART DISEASE
Abstract
Authors
KW Lauterbach E Hunsche U Klewer
KW Lauterbach E Hunsche U Klewer
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now